Targeting the NKG2D/NKG2D-L axis in acute myeloid leukemia
Authors:
Open Access
- 1 May 2021
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 137, 111299
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20192BAB205100)
- Health and Family Planning Commission of Jiangxi Province (20195334)
This publication has 125 references indexed in Scilit:
- Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE studyHaematologica, 2012
- NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responsesNature Medicine, 2012
- Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1Blood, 2011
- Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cellsProceedings of the National Academy of Sciences, 2011
- Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and MetalloproteinasesThe Journal of Immunology, 2010
- The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AMLScience, 2010
- Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient MiceImmunity, 2009
- Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cellsHaematologica, 2009
- Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cellsInternational Journal of Cancer, 2009
- The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-κB and activate T cellsNature Immunology, 2009